Citation

Mak M, de Koning P. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995; 19(6): 993-1017.

Affiliation

Clinical Pharmacology Department, Solvay Duphar, The Netherlands.

Copyright

(Copyright © 1995, Elsevier Publishing)

DOI

unavailable

PMID

8584687

Abstract

1. Experience from scale validation studies and from controlled drug trials provided clues for optimalisation of studies in aggressive patients. 2. Definitions of target behaviour, selection of patients and measurement of aggression are reviewed and recommendations are presented.

Language: en